Molecular targets of dietary polyphenols with anti-inflammatory properties

被引:270
作者
Yoon, JH
Baek, SJ
机构
[1] Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37996 USA
[2] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120749, South Korea
[3] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul 120749, South Korea
关键词
polypbenol; anti-inflammation; COX; LOX; NAG-1; NSAID;
D O I
10.3349/ymj.2005.46.5.585
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is persuasive epidemiological and experimental evidence that dietary polyphenols have anti-inflammatory activity. Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) have long been used to combat inflammation. Recently, cyclooxygenase (COX) inhibitors have been developed and recommended for treatment of rheumatoid arthritis (RA) and osteoarthritis (OA). However, two COX inhibitors have been withdrawn from the market due to unexpected side effects. Because conventional therapeutic and surgical approaches have not been able to fully control the incidence and outcome of many inflammatory diseases, there is an urgent need to find safer compounds and to develop mechanism-based approaches for the management of these diseases. Polyphenols are found in many dietary plant products, including fruits, vegetables, beverages, herbs, and spices. Several of these compounds have been found to inhibit the inflammation process as well as tumorigenesis in experimental animals; they can also exhibit potent biological properties. In addition, epidemiological studies have indicated that populations who consume foods rich in specific polyphenols have lower incidences of inflammatory disease. This paper provides an overview of the research approaches that can be used to unravel the biology and health effects of polyphenols. Polyphenols have diverse biological effects, however, this review will focus on some of the pivotal molecular targets that directly affect the inflammation process.
引用
收藏
页码:585 / 596
页数:12
相关论文
共 85 条
[21]   Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines [J].
Detmer, K ;
Steele, TA ;
Shoop, MA ;
Dannawi, H .
BLOOD CELLS MOLECULES AND DISEASES, 1999, 25 (21) :310-323
[22]   The PPAR alpha-leukotriene B-4 pathway to inflammation control [J].
Devchand, PR ;
Keller, H ;
Peters, JM ;
Vazquez, M ;
Gonzalez, FJ ;
Wahli, W .
NATURE, 1996, 384 (6604) :39-43
[23]   PPARγ3 mRNA:: a distinct PPARγ mRNA subtype transcribed from an independent promoter [J].
Fajas, L ;
Fruchart, JC ;
Auwerx, J .
FEBS LETTERS, 1998, 438 (1-2) :55-60
[24]   The organization, promoter analysis, and expression of the human PPAR gamma gene [J].
Fajas, L ;
Auboeuf, D ;
Raspe, E ;
Schoonjans, K ;
Lefebvre, AM ;
Saladin, R ;
Najib, J ;
Laville, M ;
Fruchart, JC ;
Deeb, S ;
VidalPuig, A ;
Flier, J ;
Briggs, MR ;
Staels, B ;
Vidal, H ;
Auwerx, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18779-18789
[25]   Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? [J].
Fiorucci, S ;
Meli, R ;
Bucci, M ;
Cirino, G .
BIOCHEMICAL PHARMACOLOGY, 2001, 62 (11) :1433-1438
[26]   Coxibs and cardiovascular disease [J].
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) :1709-1711
[27]   INHIBITION OF PROSTAGLANDIN SYNTHETASE IN BRAIN EXPLAINS ANTIPYRETIC ACTIVITY OF PARACETAMOL (4-ACETAMIDOPHENOL) [J].
FLOWER, RJ ;
VANE, JR .
NATURE, 1972, 240 (5381) :410-&
[28]   Mechanism-based in vitro screening of potential cancer chemopreventive agents [J].
Gerhäuser, C ;
Klimo, K ;
Heiss, E ;
Neumann, I ;
Gamal-Eldeen, A ;
Knauft, J ;
Liu, GY ;
Sitthimonchai, S ;
Frank, N .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2003, 523 :163-172
[29]   EFFECTS OF FLAVONOIDS ON NAJA-NAJA AND HUMAN RECOMBINANT SYNOVIAL PHOSPHOLIPASES A(2) AND INFLAMMATORY RESPONSES IN MICE [J].
GIL, B ;
SANZ, MJ ;
TERENCIO, MC ;
FERRANDIZ, ML ;
BUSTOS, G ;
PAYA, M ;
GUNASEGARAN, R ;
ALCARAZ, MJ .
LIFE SCIENCES, 1994, 54 (20) :PL333-PL338
[30]   Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A(2) with anti-inflammatory activity [J].
Gil, B ;
Sanz, MJ ;
Terencio, MC ;
Gunasegaran, R ;
Paya, M ;
Alcaraz, MJ .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (05) :733-740